Prudential Financial Inc. increased its position in shares of Masimo Corporation (NASDAQ:MASI) by 14.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 553,215 shares of the medical equipment provider’s stock after buying an additional 69,810 shares during the period. Prudential Financial Inc. owned 1.07% of Masimo Corporation worth $50,442,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the stock. JPMorgan Chase & Co. increased its stake in shares of Masimo Corporation by 11.2% in the first quarter. JPMorgan Chase & Co. now owns 455,338 shares of the medical equipment provider’s stock worth $42,466,000 after buying an additional 45,833 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Masimo Corporation by 36.9% in the first quarter. Geode Capital Management LLC now owns 645,254 shares of the medical equipment provider’s stock worth $60,175,000 after buying an additional 173,931 shares during the last quarter. Swiss National Bank increased its stake in shares of Masimo Corporation by 0.9% in the first quarter. Swiss National Bank now owns 77,800 shares of the medical equipment provider’s stock worth $7,256,000 after buying an additional 700 shares during the last quarter. NN Investment Partners Holdings N.V. bought a new stake in shares of Masimo Corporation during the second quarter worth about $785,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new stake in shares of Masimo Corporation during the first quarter worth about $1,223,000. 83.27% of the stock is currently owned by hedge funds and other institutional investors.

Masimo Corporation (NASDAQ:MASI) opened at 82.00 on Wednesday. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71. The company has a 50 day moving average of $90.44 and a 200-day moving average of $90.72. The stock has a market cap of $4.26 billion, a P/E ratio of 13.44 and a beta of 0.80.

Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The firm had revenue of $192.90 million for the quarter, compared to the consensus estimate of $189.03 million. During the same period in the previous year, the business earned $0.57 earnings per share. The company’s revenue for the quarter was up 11.8% compared to the same quarter last year. Equities analysts forecast that Masimo Corporation will post $2.80 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Masimo Corporation (MASI) Position Boosted by Prudential Financial Inc.” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/30/masimo-corporation-masi-position-boosted-by-prudential-financial-inc.html.

A number of equities analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of Masimo Corporation from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 11th. Stifel Nicolaus reissued a “buy” rating and issued a $108.00 price objective (up previously from $105.00) on shares of Masimo Corporation in a report on Thursday, August 3rd. BidaskClub downgraded shares of Masimo Corporation from a “buy” rating to a “hold” rating in a report on Wednesday, July 5th. Roth Capital raised their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. Finally, BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. Masimo Corporation has a consensus rating of “Hold” and a consensus price target of $95.00.

In related news, COO Anand Sampath sold 40,000 shares of Masimo Corporation stock in a transaction that occurred on Tuesday, July 11th. The stock was sold at an average price of $92.00, for a total value of $3,680,000.00. Following the sale, the chief operating officer now directly owns 20,000 shares in the company, valued at $1,840,000. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Sanford Fitch sold 6,000 shares of Masimo Corporation stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $91.89, for a total value of $551,340.00. Following the completion of the sale, the director now owns 89,249 shares in the company, valued at $8,201,090.61. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 126,000 shares of company stock worth $11,732,930. Company insiders own 16.60% of the company’s stock.

Masimo Corporation Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.